Iran strikes keep markets on tenterhooks as West Asia conflict escalates

Iran strikes keep markets on tenterhooks as West Asia conflict escalates



Indian equities declined for a second consecutive session on Thursday, with the Nifty slipping into correction territory, as Iran’s continued attacks on ships across West Asia dampened hopes of an early end to the conflict. 


The escalation also raised concerns about a prolonged disruption to oil flows through the Strait of Hormuz. 


The Sensex ended the session at 76,034, down 829 points, or 1.08 per cent. The Nifty closed at 23,639, declining 228 points, or 1 per cent. 


Since the beginning of the conflict, the Sensex has fallen 6.5 per cent and the Nifty 6.1 per cent. From their all-time highs, the Sensex is down 11.4 per cent and the Nifty 10.2 per cent. A decline of 10 per cent from recent peaks is typically defined as a “correction”, a technical indicator signalling a phase of market weakness. 

 


The total market capitalisation of BSE-listed firms declined by ₹1.8 trillion to ₹440 trillion. 


Since the onset of the conflict, overall market capitalisation has eroded by ₹23.4 trillion. 


Brent crude once again touched $100 a barrel amid reports of Iran-linked attacks on oil-transport facilities in West Asia. 


News reports suggested that explosive-laden Iranian boats attacked and set ablaze two tankers in Iraqi waters on Thursday. Additional reports of vessels being struck across the region further rattled investor nerves.

 


Iran has warned it will block oil supplies through the Strait of Hormuz until US-Israel attacks cease. Meanwhile, Hezbollah — the Iran-backed militant group based in Lebanon — launched drones and rockets at northern Israel on Wednesday, prompting Israeli strikes on Beirut’s southern suburbs and southern Lebanon. The escalation has also raised fears that Yemen’s Houthis could join the conflict in support of Iran.

 


Elevated crude oil prices leave India economically vulnerable, as the country imports nearly 90 per cent of its crude oil and about half of its natural gas requirements. A prolonged conflict in West Asia could widen India’s current account deficit and stoke inflationary flames.

 


Reflecting the stress, the rupee hit a fresh intraday low of 92.37 before settling at 92.19 against the US dollar.

 


“Geopolitical tensions in West Asia continue to dampen global risk appetite. Fresh attacks on oil-shipping vessels have pushed crude prices closer to $100 per barrel, intensifying concerns over inflation and gas supply constraints,” said Vinod Nair, head of research at Geojit Investments.

 


“In the near term, sustained risk-off sentiment and continued foreign institutional investor outflows could keep equities and the rupee under pressure. However, India’s valuation premium has narrowed this year, making the market more attractive for long-term investors and limiting downside risks,” he added.

 


Market breadth remained weak, with 1,598 stocks advancing and 2,645 declining on the BSE.

 


“Going ahead, the 23,550-23,500 zone will act as a key support level for the index. A sustained move below 23,500 could trigger further downside towards 23,350. On the upside, 23,800-23,850 remains an immediate resistance zone, while a decisive breakout above 23,850 could lead to a pullback rally towards the 23,970-24,000 zone,” said Sudeep Shah, head of technical and derivatives research at SBI Securities.

 


Among Sensex constituents, ICICI Bank fell 2.2 per cent and was the biggest drag on the index. 

Foreign Portfolio Investors (FPIs) were net sellers to the tune of ₹7,050 crore, while domestic institutions were net buyers to the tune of ₹7,450 crore. 

 



Source link

Sigma Advanced System exits non-core pharma investment

Sigma Advanced System exits non-core pharma investment


With sale of entire stake held in Extrovis AG for a consideration of Rs 137.61 crore

Sigma Advanced System has completed the divestment of its entire 36.52% equity stake in Extrovis AG, a Switzerland-based pharmaceutical company. The transaction has generated $15 million (approximately Rs 137.61 crore), providing the company with additional financial flexibility as it accelerates the expansion of its aerospace and defence business.

The divestment forms part of Sigma’s ongoing portfolio rationalisation strategy, and the company has transformed into a pureplay aerospace and defence platform. By exiting a non-core pharmaceutical investment, Sigma is freeing up capital that can now be deployed toward strengthening manufacturing capabilities, pursuing strategic acquisitions, and expanding its presence across global defence and aerospace supply chains.

 

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 12 2026 | 7:16 PM IST



Source link

Sigma Advanced System exits non-core pharma investment

AURUM sells buildings worth Rs 112 cr to fund its AI-led PropTech platforms


Aurum Proptech today announced that its Board of Directors has approved the sale of Buildings Q5 and Q6 at Millennium Business Park, Navi Mumbai, for a total consideration of Rs 112 crore, approximately 15% above the valuation provided by the valuers.

The transaction forms part of Aurum PropTech’s broader strategic shift toward AI-driven PropTech platforms, with the company committing significant capital toward building advanced artificial intelligence capabilities across the real estate ecosystem. The proceeds from the
transaction will further strengthen Aurum’s growing AI investment pool and support the accelerated development of intelligent digital infrastructure for the real estate sector.

The assets have a approximate book value of Rs 27 crore, and the transaction will generate a substantial profit, thereby enhancing the Group’s profitability metrics and strengthening its balance sheet.

 

Following the completion of the transaction, Aurum PropTech is expected to become debt-free, as the sale proceeds will be utilized to prepay Lease Rental Discounting facility (LRD) of Rs 56 crore.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 12 2026 | 7:16 PM IST



Source link

Sigma Advanced System exits non-core pharma investment

Board of Jagsonpal Pharmaceuticals approves shares buyback of Rs 40 cr


At meeting held on 12 March 2026

The Board of Jagsonpal Pharmaceuticals at its meeting held on 12 March 2026 approved a proposal to buyback up to 16,00,000 fully paid-up equity shares of the company at a price of Rs 250 per equity shares (a premium of through Tender Offer method, subject to shareholders approval. This represents 2.4% of the total equity shares of the Company and 7.3% of the non-promoter shareholding of the company. The proposed buyback will be undertaken for an aggregate amount not exceeding Rs 40 crore, representing ~18.4% of the company’s total paid-up equity share capital and free reserves based on the latest audited financial statements as of 31 March 2025.

Powered by Capital Market – Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 12 2026 | 7:16 PM IST



Source link

Sebi proposes easier rules for transmission of securities, raises limits

Sebi proposes easier rules for transmission of securities, raises limits


The regulator proposed increasing the threshold for simplified documentation to ₹10 lakh for securities held in physical mode per listed entity or mutual fund units in statement of account form per asset management company, from ₹5 lakh currently.


The Securities and Exchange Board of India (Sebi) on Thursday issued a consultation paper proposing changes to documentation requirements for transmission of securities and revision of threshold limits for simplified documentation. 


The regulator proposed increasing the threshold for simplified documentation to ₹10 lakh for securities held in physical mode per listed entity or mutual fund units in statement of account form per asset management company, from ₹5 lakh currently. For securities held in dematerialised mode, the limit has been proposed to be increased to ₹30 lakh per beneficial owner from ₹15 lakh. 


Sebi has also proposed introducing straight-through processing for low-value cases. Under the proposal, claims up to ₹10,000 in physical mode and ₹30,000 in dematerialised mode would be processed with minimal documentation.

 

First Published: Mar 12 2026 | 7:10 PM IST



Source link

Sigma Advanced System exits non-core pharma investment

Zydus to launch CGM devices with AI-intelligence powered insights


Zydus Lifesciences announced its new offering companion diagnostics portfolio. The company will be launching Diasens and GlucoLive, next-generation Continuous Glucose Monitoring (CGM) devices that combine artificial intelligence powered insights, and integrated remote care capabilities. The CGM system is designed to monitor glucose with an integrated AI layer to provide analytics and enable a closed-loop care ecosystem connecting patients, caregivers, and clinicians in real time.

Zydus has partnered with Digicare Health Solutions (TatvaCare), a healthcare technology company to help the patients gain access to its proprietary, integrated care ecosystem GoodFlip to provide AI-powered report analysis, personalised diet and exercise coaching, doctor consultations, diagnostic lab booking, and a comprehensive medical record vault – all in a single mobile application.

 

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 12 2026 | 7:04 PM IST



Source link

YouTube
Instagram
WhatsApp